Aardvark Therapeutics, Inc. (AARD)

Market Closed

16 Oct, 08:00 PM

NASDAQ (NGS)

$

3. 78

-0.08

-2.0725%

82.72M Market Cap

- P/E Ratio

- Div Yield

97,200 Volume

- Eps

$ 3.86

Previous Close

Investors:

Add Transaction

Day Range

3.73 4.19

Year Range

3.35 16.6

Want to track AARD and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Aardvark Therapeutics, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Curtis Ellergodt Rothschild Investment LLC	265	$1,011.92	$1,028.2	$16.28	1.61%
JD Jim Dushek HARBOUR INVESTMENTS Inc.	53	$202.12	$205.64	$3.52	1.74%
DS Danny Salinas Cantor Fitzgerald LP	116,582	$868,097.82	$459,333.08	-$408,764.74	-47.09%
Point72 Asset Management LP Point72 Asset Management LP	22,872	$87,828.48	$88,285.92	$457.44	0.52%
Bobby Adusumilli SJS Investment Consulting Inc.	16	$61.3	$61.76	$0.46	0.75%
Li Peng China Universal Asset Management Co. Ltd.	3,472	$42,629.6	$13,231.79	-$29,397.81	-68.96%
Drew Phillips Fortitude Family Office LLC	11	$42.24	$42.46	$0.22	0.52%
Kevin Kroskey True Wealth Design LLC	27	$103.68	$104.22	$0.54	0.52%
Christopher C. Powers Farther Finance Advisors, LLC	17	$65.28	$65.96	$0.68	1.04%
JWM JPL Wealth Management LLC JPL Wealth Management, LLC	7	$26.88	$27.02	$0.14	0.52%
Ashley Meredith Abel Hall, LLC	10,066	$38,653.44	$39,157.75	$504.31	1.3%
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	452	$5,408.28	$1,760.86	-$3,647.42	-67.44%

1

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.